Page last updated: 2024-11-07

acromelic acid a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acromelic acid A: isolated from poisonous mushroom Clitocybe acromelaga; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

acromelic acid A : A pyrrolidinecarboxylic acid that is siolated from the poisonous mushroom Clitocybe amoenolens. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID108086
CHEMBL ID4756304
CHEBI ID134690
SCHEMBL ID2059218
MeSH IDM0147119

Synonyms (15)

Synonym
2-pyridinecarboxylic acid, 5-(5-carboxy-4-(carboxymethyl)-3-pyrrolidinyl)-1,6-dihydro-6-oxo-, (3s-(3alpha,4alpha,5beta))-
2-pyridinecarboxylic acid, 5-((3s,4s,5s)-5-carboxy-4-(carboxymethyl)-3-pyrrolidinyl)-1,6-dihydro-6-oxo-
acromelic acid a
5-[(3s,4s,5s)-5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]-6-oxo-1,6-dihydropyridine-2-carboxylic acid
86630-09-3
CHEBI:134690
5-[(3s,4s,5s)-5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]-6-oxo-1h-pyridine-2-carboxylic acid
C19949
mdu5184y3c ,
unii-mdu5184y3c
2-pyridinecarboxylic acid, 5-(5-carboxy-4-(carboxymethyl)-3-pyrrolidinyl)-1,6-dihydro-6-oxo-, (3s-(3.alpha.,4.alpha.,5.beta.))-
SCHEMBL2059218
Q27283937
DTXSID70897146
CHEMBL4756304

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Prolonged infusion of very small amounts of DCG-IV showed a bell-shaped dose-response relationship with regard to protection against kainate-induced neurotoxicity."( [Pharmacology of the glutamate receptor].
Shinozaki, H, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
NMDA receptor agonistAn excitatory amino acid agonist which binds to NMDA receptors and triggers a response.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
neurotoxinA poison that interferes with the functions of the nervous system.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pyrrolidinecarboxylic acid
tricarboxylic acidAn oxoacid containing three carboxy groups.
pyridone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1682232Neurotoxicity in ip dosed mouse assessed as induction of hindlimb tonic extension2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682231Neurotoxicity in ip dosed mouse assessed as induction of epileptic convulsion2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682230Neurotoxicity in ip dosed mouse assessed as mouse death2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.50)18.7374
1990's14 (43.75)18.2507
2000's7 (21.88)29.6817
2010's6 (18.75)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.35 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]